average weight loss compounded semaglutide for Management The Pros and Cons of

Estudios como el REWING con dulaglutida y especialmente el SUSTAIN-6 con semaglutida, demostraron una disminucin del 24% (HR, 0.76 [95% CI, 0.610.95];P=0.017) y 39% (HR, 0.61 [95% CI, 0.380.99]

Its not clear why a substantial minority of individuals dont lose weight when taking a GLP-1 this is a question of tremendous scientific and clinical importance. His own recent study in JAMA Internal Medicine suggests that the drugs work similarly across patient groups based on factors such as age, race and whether people have diabetes, but he said its entirely plausible that there are genetic determinants of GLP-1 effectiveness that have yet to be identified

The shorter window reflects tirzepatide shorter half-life

I hope its helpful to you.